Brief: Vallon Pharmaceuticals Reports Second Quarter 2022 Financial Results
28/07/2022 13:17
July 28 (Reuters) - Vallon Pharmaceuticals Inc VLON.O :
* VALLON PHARMACEUTICALS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATE
* VALLON PHARMACEUTICALS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATE
* VALLON PHARMACEUTICALS - NET LOSS WAS $1.8 MILLION FOR QUARTER ENDED JUNE
30,
2022
Source text for Eikon: ID:nGNX99yBzG
Further company coverage: VLON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GRI Bio
See all newsGRI Bio Inc reports results for the quarter ended June 30 - Earnings Summary
GRI Bio Inc expected to post a loss of $1.19 a share - Earnings Preview
Brief: Gri Bio Secures FDA Orphan Drug Designation For Gri-0621 (Tazarotene) In Idiopathic Pulmonary Fibrosis
GRI Bio Q1 net loss narrows on lower R&D expenses
GRI Bio raises $14.5 mln to fund operations into Q1 2027